Azithromycin tab 250 mg: Discontinuation

The supply of azithromycin 250 mg tablets has been discontinued. It will be delisted once supplies run out.

25 May 2022 update

The Apotex 250 mg tablet has been relisted for 1 June 2022 to use up the remaining stocks in the supply chain.

Why are we doing this?

Apotex is discontinuing the supply of azithromycin 250 mg tablets. We have secured an alternative brand of the 500 mg strength of azithromycin, which will remain available. 

We know that there is still a need for a 250 mg tablet and we're trying to find a supplier.

Latest updates on Apotex products

Key dates

October 2021: stock exhausted

We anticipate that stocks of azithromycin 250 mg tablets will be exhausted in October 2021.  

1 May 2022: tablets delisted

The May 2022 delisting date allows for dispensing of residual stock within the supply chain. 

1 June 2022: tablets relisted

We have been advised that there is further stocks of the 250 mg tablet in the supply chain. As such, we've relisted it temporarily.

Alternative product 

We have secured supply of the Zithromax brand of azithromycin 500 mg tablets. Unfortunately there's no score mark on the tablet. We know that there is still a need for a 250 mg tablet and we're trying to find a supplier.

Read more detail about the ongoing supply of azithromycin tab 500 mg 

Who to contact

If you have any questions, email enquiry@pharmac.govt.nz